Insider Buy/Sell Details for the Biotechnology Industry — Last 7 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (317)
Rapport Therapeutics, Inc. (RAPP)
Gault Cheryl — Chief Operating Officer
Shares
1,000
Price
$43.15
Total Value
$43.15K
Shares Held After
149,914
% of Holdings
0.7%
Rapport Therapeutics, Inc. (RAPP)
Gault Cheryl — Chief Operating Officer
Shares
3,308
Price
$42.17
Total Value
$139.51K
Shares Held After
150,914
% of Holdings
2.1%
Rapport Therapeutics, Inc. (RAPP)
Gault Cheryl — Chief Operating Officer
Shares
3,792
Price
$41.39
Total Value
$156.96K
Shares Held After
154,222
% of Holdings
2.4%
Rapport Therapeutics, Inc. (RAPP)
Gault Cheryl — Chief Operating Officer
Shares
1,900
Price
$40.09
Total Value
$76.17K
Shares Held After
158,014
% of Holdings
1.2%
BioAge Labs, Inc. (BIOA)
Barton Shane — Principal Accounting Officer
Shares
20,216
Price
$25.19
Total Value
$509.18K
Shares Held After
0
% of Holdings
100.0%
Zai Lab Ltd (ZLAB)
Du Ying — Director
Shares
7,026
Price
$18.53
Total Value
$130.22K
Shares Held After
1,203,784
% of Holdings
0.6%
X4 Pharmaceuticals, Inc (XFOR)
KIRSKE DAVID — Chief Financial Officer
Shares
8,543
Price
$4.26
Total Value
$36.43K
Shares Held After
167,750
% of Holdings
4.8%
Alpha Tau Medical Ltd. (DRTS)
Levy Raphi — Chief Financial Officer
Shares
20,000
Price
$12.00
Total Value
$240.04K
Shares Held After
90,180
% of Holdings
18.2%
Roivant Sciences Ltd. (ROIV)
MANCHESTER KEITH S — Director
Shares
200,000
Price
$35.45
Total Value
$7.09M
Shares Held After
1,748,403
% of Holdings
10.3%
Roivant Sciences Ltd. (ROIV)
MANCHESTER KEITH S — Director
Shares
12,380
Price
$35.28
Total Value
$436.77K
Shares Held After
13,689,166
% of Holdings
0.1%
Roivant Sciences Ltd. (ROIV)
Gold Daniel Allen — Director
Shares
12,380
Price
$35.28
Total Value
$436.77K
Shares Held After
13,689,166
% of Holdings
0.1%
Roivant Sciences Ltd. (ROIV)
QVT Financial LP — Director by Deputization
Shares
12,380
Price
$35.28
Total Value
$436.77K
Shares Held After
13,689,166
% of Holdings
0.1%
Mineralys Therapeutics, Inc. (MLYS)
Congleton Jon — Director
Shares
17,000
Price
$26.82
Total Value
$455.90K
Shares Held After
614,321
% of Holdings
2.7%
Mineralys Therapeutics, Inc. (MLYS)
Congleton Jon — Director
Shares
58,000
Price
$25.94
Total Value
$1.50M
Shares Held After
631,321
% of Holdings
8.4%
Candel Therapeutics, Inc. (CADL)
Tyagarajan Seshu — Chief Technology Officer
Shares
7,000
Price
$10.02
Total Value
$70.15K
Shares Held After
83,865
% of Holdings
7.7%
Candel Therapeutics, Inc. (CADL)
Barone Francesca — Chief Scientific Officer
Shares
23,447
Price
$10.06
Total Value
$235.77K
Shares Held After
77,362
% of Holdings
23.3%
Protara Therapeutics, Inc. (TARA)
Shefferman Jesse — Director
Shares
215,687
Price
$4.09
Total Value
$882.16K
Shares Held After
721,832
% of Holdings
23.0%
Maze Therapeutics, Inc. (MAZE)
Dandekar Atul — CSBO
Shares
7,500
Price
$28.02
Total Value
$210.15K
Shares Held After
26,250
% of Holdings
22.2%
BioAge Labs, Inc. (BIOA)
Barton Shane — Principal Accounting Officer
Shares
42,350
Price
$25.21
Total Value
$1.07M
Shares Held After
0
% of Holdings
100.0%
Roivant Sciences Ltd. (ROIV)
MANCHESTER KEITH S — Director
Shares
600,000
Price
$34.59
Total Value
$20.75M
Shares Held After
13,701,546
% of Holdings
4.2%
Roivant Sciences Ltd. (ROIV)
MANCHESTER KEITH S — Director
Shares
200,000
Price
$34.44
Total Value
$6.89M
Shares Held After
14,301,546
% of Holdings
1.4%
Roivant Sciences Ltd. (ROIV)
Gold Daniel Allen — Director
Shares
600,000
Price
$34.59
Total Value
$20.75M
Shares Held After
13,701,546
% of Holdings
4.2%
Roivant Sciences Ltd. (ROIV)
Gold Daniel Allen — Director
Shares
200,000
Price
$34.44
Total Value
$6.89M
Shares Held After
14,301,546
% of Holdings
1.4%
Climb Bio, Inc. (CLYM)
Brennan Aoife — Director
Shares
30,902
Price
$13.17
Total Value
$406.98K
Shares Held After
87,731
% of Holdings
26.0%
Roivant Sciences Ltd. (ROIV)
QVT Financial LP — Director by Deputization
Shares
600,000
Price
$34.59
Total Value
$20.75M
Shares Held After
13,701,546
% of Holdings
4.2%
Roivant Sciences Ltd. (ROIV)
QVT Financial LP — Director by Deputization
Shares
200,000
Price
$34.44
Total Value
$6.89M
Shares Held After
14,301,546
% of Holdings
1.4%
Adaptive Biotechnologies Corp (ADPT)
BENZENO SHARON — Chief Commercial Ofc Imm Med
Shares
154,768
Price
$21.14
Total Value
$3.27M
Shares Held After
221,278
% of Holdings
41.2%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
40,702
Price
$21.14
Total Value
$860.44K
Shares Held After
975,931
% of Holdings
4.0%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
51,756
Price
$21.14
Total Value
$1.09M
Shares Held After
1,344,719
% of Holdings
3.7%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
102,969
Price
$21.14
Total Value
$2.18M
Shares Held After
4,476,487
% of Holdings
2.2%
GALECTIN THERAPEUTICS INC (GALT)
Jamil Khurram — Chief Medical Officer
Shares
47,467
Price
$5.04
Total Value
$239.23K
Shares Held After
0
% of Holdings
100.0%
GALECTIN THERAPEUTICS INC (GALT)
Shlevin Harold H. — Director
Shares
22,268
Price
$5.04
Total Value
$112.23K
Shares Held After
6,500
% of Holdings
77.4%
Septerna, Inc. (SEPN)
Shaikhly Samira — Chief People Officer
Shares
2,178
Price
$35.18
Total Value
$76.62K
Shares Held After
793
% of Holdings
73.3%
Disc Medicine, Inc. (IRON)
Khara Rahul — Chief Legal Officer
Shares
1,649
Price
$75.00
Total Value
$123.67K
Shares Held After
52,173
% of Holdings
3.1%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
3,024
Price
$107.76
Total Value
$325.87K
Shares Held After
466,077
% of Holdings
0.6%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
2,318
Price
$106.63
Total Value
$247.17K
Shares Held After
469,101
% of Holdings
0.5%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
848
Price
$105.78
Total Value
$89.70K
Shares Held After
471,419
% of Holdings
0.2%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
19,093
Price
$107.76
Total Value
$2.06M
Shares Held After
2,412,747
% of Holdings
0.8%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
14,613
Price
$106.63
Total Value
$1.56M
Shares Held After
2,431,840
% of Holdings
0.6%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
5,471
Price
$105.78
Total Value
$578.72K
Shares Held After
2,446,453
% of Holdings
0.2%
HALOZYME THERAPEUTICS, INC. (HALO)
Krishnan Mahesh — Director
Shares
7,304
Price
$75.00
Total Value
$547.80K
Shares Held After
14,462
% of Holdings
33.6%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
157
Price
$111.20
Total Value
$17.46K
Shares Held After
461,794
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
1,199
Price
$110.67
Total Value
$132.69K
Shares Held After
461,951
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
1,239
Price
$109.75
Total Value
$135.98K
Shares Held After
463,150
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
1,688
Price
$108.28
Total Value
$182.78K
Shares Held After
464,389
% of Holdings
0.4%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
907
Price
$111.20
Total Value
$100.86K
Shares Held After
2,385,747
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
7,602
Price
$110.67
Total Value
$841.31K
Shares Held After
2,386,654
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
7,833
Price
$109.75
Total Value
$859.67K
Shares Held After
2,394,256
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
10,658
Price
$108.28
Total Value
$1.15M
Shares Held After
2,402,089
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
430
Price
$548.96
Total Value
$236.05K
Shares Held After
40,513
% of Holdings
1.1%
Showing 1–50 of 317 transactions (page 1 of 7)